Skip to main content
OpenTrials

Clinical trial condition

Intestinal Diseases

Explore clinical trials studying Intestinal Diseases. Study availability and eligibility vary by location and protocol.

11,737 public trials 2,242 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Diseases trial results

Recruiting

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

NCT05806931

Conditions
Colon Cancer, Colonic Diseases, Colonic Neoplasms, +12 more
Locations
  • Trinitas Hospital and Comprehensive Cancer Center Elizabeth, New Jersey, United States
  • RWJBarnabas Health Jersey City Medical Center Jersey City, New Jersey, United States
  • RWJBarnabas Health - Monmouth Medical Center Southern Campus Lakewood, New Jersey, United States
  • Cooperman Barnabas Medical Center (Saint Barnabas Medical Center) Livingston, New Jersey, United States
View Trial Details
Recruiting

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

NCT06244771

Conditions
Advanced Solid Tumors With KRAS G12C Mutations, Bronchial Neoplasms, Carcinoma, Bronchogenic, +32 more
Locations
  • University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center La Jolla, California, United States
  • University of California Irvine (UCI) - Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
View all 26 locations
View Trial Details
Recruiting

Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer

NCT06336902

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • Saint Jude Medical Center / Providence Medical Foundation Fullerton, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View Trial Details
Recruiting

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

NCT06992258

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Mount Sinai Cancer Research Program Miami Beach, Florida, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
View Trial Details

Related conditions